ADUS Stock Analysis: Buy, Sell, or Hold?
ADUS - Addus HomeCare Corp.
$90.98
-1.43 (-1.55%)
▼
5d:
-8.63%
30d:
-2.52%
90d:
-20.05%
HOLD
MODERATE Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 11, 2026
0d
Get Alerted When ADUS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ADUS shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: ADUS shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$142.90
Based on 5.4% avg growth
INTRINSIC VALUE TODAY
$88.73
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 14.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ADUS is currently trading at $90.98, which is considered oversold relative to its 30-day fair value range of $92.94 to $98.24. From a valuation perspective, the stock is trading at a discount (Forward PE: 12.2) compared to its historical average (14.7). Remarkably, the market is currently pricing in an annual earnings decline of 6.0% over the next few years. This pessimistic expectation contrasts with the company's recent 17.2% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, ADUS is in a strong downtrend. The price is currently testing key support at $89.76. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ADUS has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $133.46 (+46.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ADUS is in a strong downtrend. The price is currently testing key support at $89.76. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ADUS has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $133.46 (+46.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$92.94 -
$98.24
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 46.7% below Wall St target ($133.46)
- CAUTION: 5-day price weakness (-8.6%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$92.94 -
$98.24
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$89.76
Resistance Level
$103.50
Current Trend
Strong Downtrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
12.17
Wall Street Target
$133.46
(+46.7%)
Revenue Growth (YoY)
7.7%
Earnings Growth (YoY)
17.2%
Profit Margin
6.9%
Valuation Discount vs History
-6.0% cheaper
PE vs Historical
12.2 vs 14.7
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-6.0%
(market-implied from PE analysis)
1-Year Target
$85.52
(-6%)
2-Year Target
$80.39
(-12%)
3-Year Target
$75.57
(-17%)
3-Yr Target (if PE normalizes)
(PE: 12→15)
$91.27
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.1, Growth: 6.8%)
$201.06
(+121%)
Base:
(SPY PE: 12.2, Growth: 6.8%)
$110.88
(+22%)
Bear:
(PE: 10.3, Growth: 6.8%)
$94.25
(+4%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (17x PE), but valuation improves significantly next year (12x PE) as earnings recover.
Trailing PE: 17.05 | Current EPS (TTM): $5.42
Bull Case
$140.19
(+54%)
Analyst growth 37.9%, PE expands to 18.8
Base Case
$127.45
(+40%)
Market implied 37.9%, PE stable at 17.1
Bear Case
$62.84
(-31%)
Severe decline -20.0%, PE contracts to 14.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 12.2 to 14.7
Stabilization Target:
$109.88
(+20.8%)
PE Expansion Potential:
+20.8%
Share & Embed Analysis
Last updated: May 18, 2026 5:09 AM ET
Data refreshes hourly during market hours. Next update: 6:09 AM
Data refreshes hourly during market hours. Next update: 6:09 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ADUS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
20
Sells
Net
INSIDERS SELLING
Recent Transactions
Cliff Donald Blessing
SELL
178 shares
2026-04-21
Brian Poff
SELL
820 shares
2026-02-25
Cliff Donald Blessing
SELL
177 shares
2026-02-25
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
HCA
HCA Holdings Inc |
BUY
25 analysts |
$513 | 64 BUY |
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$246 | 61 BUY |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 61 BUY |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$23 | 59 HOLD |
|
OPCH
Option Care Health Inc |
STRONG BUY
10 analysts |
$29 | 59 HOLD |
